Chemoprevention Uptake for Breast Cancer Risk Reduction Varies by Risk Factor

Background/Objective The efficacy of chemoprevention for breast cancer risk reduction has been demonstrated in randomized controlled trials; however, use remains low. We sought to determine whether uptake differed by risk factors, and to identify reasons for refusal and termination.